Executive Decision Making for Pharma & Biotech | November 6-8, 2023

Two Conferences at the Intersection of Science, Business, and Operations

PROGRAM & PORTFOLIO MANAGEMENT

Driving Optimized Portfolio Insights, Prioritization and Decision-Making

November 6-7

Learn More »

STRATEGIC RESOURCE MANAGEMENT

Resource Forecasting, Staff Planning and Agile Capacity Management Strategies

November 7-8

Learn More »

Advancing Biopharma R&D, Business Analytics, and Decision Making

Portfolio prioritization, decision analysis, agile capacity management, resource forecasting, risk mitigation, and overall strategic decision making are becoming increasing difficult in today’s ever-changing pharma R&D landscape. Cambridge Healthtech Institute’s Biopharma Strategy Series presents Executive Decision Making for Pharma and Biotech 2023, 3 days of high-level content, interactive discussions and networking, breakout roundtables, 1:1 meetings, and much more! Attendees will leave with new tools and organizational strategies to optimize portfolio insights and decision making; and align resource planning, allocation, and capacity management with portfolio prioritization.

SUBMIT A PROPOSAL »

SPONSOR & EXHIBIT »

FLEXIBLE REGISTRATION »

2023 Keynote Speakers

Astrid Maria Dahl

COO and Head, Innovent Biologics (Europe)

Melquiades de Jesus

Senior Director R&D PMO Business Capabilities, Jazz Pharmaceuticals

Michael Myers, PhD

Associate Vice President, LRL Project Management - Due Dilligence, Eli Lilly and Company

Charles Persinger

Executive Director, Portfolio Strategy & Decision Sciences, Eli Lilly and Company

Peter Ray

Biopharma Strategy & Operations Executive; Former Head of Strategy, Alnylam Pharmaceuticals

2023 Advisory Board

Richard Bayney, PhD

Richard Bayney, PhD

President & Founder, Project & Portfolio Value Creation

Chami Karandana Evans

Chami Karandana Evans

Executive Director, Portfolio Management & Operational Effectiveness, Insmed

Michael Ferrante

Michael Ferrante

Executive Director, Portfolio Prioritization, Global Regulatory Affairs & Clinical Safety, Merck

Sean Gallagher

Sean Gallagher

Director, Capacity Management and Business Analytics, Janssen

Leslie Lippard

Leslie Lippard

Senior Director, Portfolio Analytics, Alnylam Pharmaceuticals

Michael Myers

Michael Myers

Associate Vice President, LRL Project Management - Due Diligence, Eli Lilly & Co.

"This conference attracted a great set of attendees from companies and from vendors--the best that I have ever attended. As such, it was a great opportunity to learn from others and to catch up on broad trends. My perspective shifted from being focused 1-3 years out to really thinking about the longer term, and how to get my company from where we are today to where we need to be in the long term."
Biopharma Portfolio Manager, 2022 Attendee

VIEW SPEAKER BIOS »

Alumni Organizations